BAYER WKN: BAY001 ISIN: DE000BAY0017 Kürzel: BAYN Forum: Aktien Thema: Hauptdiskussion

Weil da die Lawine gigantisch wird

PCB ist aber das Kernproblem

Du hast es stets von Glyphosat

Der sieht es noch nicht ganz so rosig wie Du

Muss sich nur noch beim Kurs rumsprechen

When Lambo?

Deine stärkste Posi?

Wie f.ett bist Du investiert?

An der juristischen Front läuft es gerade wieder gut für Bayer

Sieht doch super aus. Die Kläger werfen hin.😅

March 8, 2024 – California Plaintiff Quits in Middle of Trial

Free Case Evaluation: 800-553-8082 TAP TO CALLTAP TO TEXT Lawsuit Information Center HOME CONTACT US MORE March 07, 2024 Monsanto Roundup Lawsuit Update by Ronald V. Miller, Jr. In this post, our Roundup lawyers will give you: an update on where things stand in the Roundup class action lawsuit in December 2023 (including updates from the last four trials, including the new $1.5 billion verdict on November 20, 2023, and the latest $2.25 billion verdict in Philadelphia on January 26, 2024). the likely direction the Roundup litigation will likely take moving forward and the expected future settlement amounts in the Bayer Roundup lawsuit (Phase 2) 54,000 Roundup Cases Left… and Counting As of March 2024, Monsanto has reached settlement agreements in nearly 100,000 Roundup lawsuits. Monsanto paid approximately $11 billion. Bayer has accomplished this by negotiating block settlement arrangements with plaintiffs’ lawyers who have significant cases in the litigation… and by settling with plaintiffs before trial. Although these settlements account for nearly two-thirds of all Roundup claims, Monsanto estimates 54,000 active Roundup lawsuits remain. Most lawsuits have been filed in state court. But over 4,000 claims in the MDL Roundup class action lawsuit are still pending in California. New Roundup lawsuits continue to be filed regularly. Our attorneys receive calls and online contact forms from Roundup victims with NHL daily. You can reach us at 800-553-8082. March 8, 2024 – California Plaintiff Quits in Middle of Trial Geez. I had higher hopes for the four cases that were in trial. One mistrial, two defense verdicts, and now a plaintiff has quit mid-trial. Why? I have no idea. I never understood the facts of Meyer and do not know whether it was a good case. There is no question Bayer will keep looking to try weak cases. So you will keep seeing defense verdicts. But you also will see more billion dollar verdicts if this litigation drags on. March 8, 2027 – Bayer CEO on Settlement This is from Bayer’s CEO on the earnings call this week: But it’s clear that a strategy of defense alone is not enough. We’re looking at the litigation topic from every angle, inside and outside the courtroom. That includes much more thorough engagement with other stakeholders in the realm of public policy. It includes considering every possible means to bring closure to these lawsuits for the company and for our customers. Bayer is being cagey and its plans for two reasons. One, it is a bad idea to telegraphic your intentions in how you will manage any piece of mass tort litigation. But I also don’t think it has a clear plan either.

Was könnte die Aktie wieder treiben. Die drei gewonnenen Prozesse sind leider verpufft.

Ja oder halt 160% in drei Monaten wie mit IOVA...

In ein Biotech SmallCap 😂😂 Leute gibt‘s. Da hast schnell mal -20% an einem Tag verloren. Mit einem viel größeren Risiko eines Totalverlustes. Wenn Du schon von „investieren“ sprichst. Eine PP jagt oft die nächste , dann RS……

Mag schon sein. Die Frage ist nur ob es nicht bessere Aktien gibt. Wenn du schon bereit bist -20% in Kauf zu nehmen kannst du auch in ein Biotech Smallcap investieren.